Legal & General Group’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.56M Buy
127,235
+4,923
+4% +$60.3K ﹤0.01% 2066
2025
Q1
$1.75M Sell
122,312
-4,199
-3% -$60.2K ﹤0.01% 1981
2024
Q4
$2.01M Buy
126,511
+630
+0.5% +$10K ﹤0.01% 1979
2024
Q3
$3.02M Sell
125,881
-2,567
-2% -$61.7K ﹤0.01% 1807
2024
Q2
$2.56M Sell
128,448
-2,539
-2% -$50.6K ﹤0.01% 1837
2024
Q1
$2.61M Sell
130,987
-29,676
-18% -$591K ﹤0.01% 1812
2023
Q4
$3.6M Sell
160,663
-17,753
-10% -$398K ﹤0.01% 1684
2023
Q3
$3.61M Buy
178,416
+3,325
+2% +$67.2K ﹤0.01% 1617
2023
Q2
$4.48M Buy
175,091
+40,203
+30% +$1.03M ﹤0.01% 1518
2023
Q1
$4.01M Sell
134,888
-44,776
-25% -$1.33M ﹤0.01% 1532
2022
Q4
$4.86M Sell
179,664
-2,075
-1% -$56.1K ﹤0.01% 1422
2022
Q3
$3.96M Sell
181,739
-720
-0.4% -$15.7K ﹤0.01% 1482
2022
Q2
$4.99M Buy
182,459
+8,778
+5% +$240K ﹤0.01% 1414
2022
Q1
$5.82M Sell
173,681
-20,468
-11% -$686K ﹤0.01% 1437
2021
Q4
$6.73M Buy
194,149
+692
+0.4% +$24K ﹤0.01% 1414
2021
Q3
$6.04M Buy
193,457
+24,323
+14% +$759K ﹤0.01% 1445
2021
Q2
$6.15M Buy
169,134
+57,569
+52% +$2.09M ﹤0.01% 1439
2021
Q1
$4.88M Buy
111,565
+42,128
+61% +$1.84M ﹤0.01% 1565
2020
Q4
$3.19M Sell
69,437
-438
-0.6% -$20.1K ﹤0.01% 1695
2020
Q3
$2.32M Buy
69,875
+1,400
+2% +$46.5K ﹤0.01% 1702
2020
Q2
$2.01M Buy
68,475
+4,146
+6% +$122K ﹤0.01% 1735
2020
Q1
$1.73M Sell
64,329
-748
-1% -$20.2K ﹤0.01% 1648
2019
Q4
$2.19M Buy
65,077
+7,476
+13% +$252K ﹤0.01% 1757
2019
Q3
$2.16M Sell
57,601
-195
-0.3% -$7.3K ﹤0.01% 1692
2019
Q2
$2.52M Sell
57,796
-4,039
-7% -$176K ﹤0.01% 1597
2019
Q1
$2.64M Buy
61,835
+760
+1% +$32.4K ﹤0.01% 1561
2018
Q4
$2.74M Buy
61,075
+3,393
+6% +$152K ﹤0.01% 1431
2018
Q3
$3.95M Sell
57,682
-108
-0.2% -$7.4K ﹤0.01% 1326
2018
Q2
$3.31M Sell
57,790
-4,753
-8% -$272K ﹤0.01% 1378
2018
Q1
$2.88M Sell
62,543
-13,768
-18% -$634K ﹤0.01% 1414
2017
Q4
$3.53M Sell
76,311
-45
-0.1% -$2.08K ﹤0.01% 1292
2017
Q3
$3.44M Buy
76,356
+5,043
+7% +$227K ﹤0.01% 1259
2017
Q2
$2.8M Buy
71,313
+6,392
+10% +$251K ﹤0.01% 1340
2017
Q1
$2.47M Buy
64,921
+3,415
+6% +$130K ﹤0.01% 1340
2016
Q4
$2.28M Buy
61,506
+10,926
+22% +$404K ﹤0.01% 1300
2016
Q3
$1.75M Buy
50,580
+930
+2% +$32.1K ﹤0.01% 1132
2016
Q2
$1.61M Buy
49,650
+5,562
+13% +$180K ﹤0.01% 1029
2016
Q1
$1.27M Buy
44,088
+12,197
+38% +$351K ﹤0.01% 1058
2015
Q4
$1.07M Buy
31,891
+2,175
+7% +$72.7K ﹤0.01% 1142
2015
Q3
$842K Buy
29,716
+1,790
+6% +$50.7K ﹤0.01% 1166
2015
Q2
$1.13M Buy
27,926
+6,547
+31% +$265K ﹤0.01% 1114
2015
Q1
$1.05M Sell
21,379
-164,223
-88% -$8.07M ﹤0.01% 1100
2014
Q4
$8.44M Buy
+185,602
New +$8.44M 0.01% 677